Annotated Medicine and Device Lists

Hydralazine

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines Others observations:
Hydralazine is listed for use in the acute management of severe pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of more evidence of efficacy and safety of other medicines.
PAHO Strategic Fund Medicine List 6.1. Antihypertensive medicines No observations
Bolivia LINAME 2011 - 2013 No observations
Ecuador Essential Medicines List - Ecuador No observations
Chile Essential and Prioritized Medications No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines Others observations:
Hydralazine is listed for use in the acute management of severe pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of more evidence of efficacy and safety of other medicines.
PAHO Strategic Fund Medicine List 6.1. Antihypertensive medicines No observations
Chile Essential and Prioritized Medications No observations
Colombia 05.3 Anti-Hypertensives No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines Others observations:
Hydralazine is listed for use in the acute management of severe pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of more evidence of efficacy and safety of other medicines.
PAHO Strategic Fund Medicine List 6.1. Antihypertensive medicines No observations
Bolivia LINAME 2011 - 2013 No observations
Ecuador Essential Medicines List - Ecuador No observations
Chile Essential and Prioritized Medications No observations

This medicine is present in:

List Section Observation
Bolivia LINAME 2011 - 2013 No observations

Information Resources: Hydralazine